LONZA GROUP AG :Lonza And Vertex Sign A Long-Term Commercial Supply Agreement For Casgevy® (Exagamglogene Autotemcel).Lonza Group Ag - To Manufacture World'S First Crispr/Cas9 Cell Therapy.Lonza Group Ag - Geleen (Nl) Site Is Now Approved By Fda, Ema And Mhra For Commercial Production Of Casgevy^®.Lonza Group Ag - Casgevy To Be Manufactured At Lonza'S Geleen Facility.Lonza Group Ag - Geleen Site Approved By Fda, Ema, Mhra For Casgevy Production.Lonza Group Ag - Portsmouth Site Expected To Begin Gmp Operations In 2025.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。